Gary N Schwartz, MD
Dartmouth-Hitchcock Medical Center · Norris Cotton Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gary N Schwartz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:32 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02384746 · Phase I Study of the Combination of MLN9708 and FulvestrantDartmouth-Hitchcock Medical Center · terminated · Breast Cancer · principal investigator
- N/ANCT01617915 · Tumor Specific Plasma DNADartmouth-Hitchcock Medical Center · completed · Breast Cancer, Lung Cancer · principal investigator
- Ph1NCT00354900 · Phase I Study of Aprotinin in Advanced Breast CancerDartmouth-Hitchcock Medical Center · terminated · Metastatic Breast Cancer · principal investigator
- Ph2NCT00225758 · Lapatinib in Metastatic Breast Cancer Resistant to Hormone TherapyGary Schwartz · terminated · Metastatic Breast Cancer · principal investigator
- Ph1NCT00169000 · Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat CancersDartmouth-Hitchcock Medical Center · completed · Metastatic Breast Cancer · study chair
- Ph2/Ph3NCT00169104 · Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell FunctionDartmouth-Hitchcock Medical Center · terminated · Metastatic Breast Cancer · principal investigator
- Ph1NCT00003294 · Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerRoswell Park Cancer Institute · completed · Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph2NCT00080743 · Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast CancerDartmouth-Hitchcock Medical Center · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Administrative CoreP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dale Henry · fiscal years 2008 to 2026Named on NCT00003294
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.